Literature DB >> 36058984

Transcriptomic Analysis of DNA Repair Pathways in Human Non-Small Cell Lung Cancer Cells Surviving Multifraction X-Ray Irradiation.

M V Pustovalova1,2, A A Guryanova3, M I Sorokin3,4, M V Suntsova4, A A Buzdin3,4, L Alhaddad3, A N Osipov3,5, S V Leonov3.   

Abstract

Radioresistant sublines of non-small cell lung cancer cells differing in the p53 status were obtained: A549 (p53 wild type) and H1299 (p53 deficient). The exposure to ionizing radiation was carried out using a standard protocol developed on the basis of empirical clinical experience and consisting in exposure in a dose of 2 Gy once a day, 5 days a week up to total dose of 60 Gy. The cells survived after irradiation demonstrated reduced radiosensitivity, as well as changes in differential gene expression in comparison with parental cells. Some differences in the signaling pathways involved in DNA repair were revealed.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  DNA repair; ionizing radiation; non-small cell lung cancer; radioresistance; transcriptomics

Mesh:

Substances:

Year:  2022        PMID: 36058984     DOI: 10.1007/s10517-022-05586-0

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.737


  10 in total

1.  Clinically relevant radioresistant cells efficiently repair DNA double-strand breaks induced by X-rays.

Authors:  Yoshikazu Kuwahara; Li Li; Taisuke Baba; Hironobu Nakagawa; Tsutomu Shimura; Yoichiro Yamamoto; Yasuhito Ohkubo; Manabu Fukumoto
Journal:  Cancer Sci       Date:  2009-02-02       Impact factor: 6.716

2.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

3.  Overcoming anoikis--pathways to anchorage-independent growth in cancer.

Authors:  Marta C Guadamillas; Ana Cerezo; Miguel A Del Pozo
Journal:  J Cell Sci       Date:  2011-10-01       Impact factor: 5.285

4.  Artemis-dependent DNA double-strand break formation at stalled replication forks.

Authors:  Junya Unno; Masatoshi Takagi; Jinhua Piao; Masataka Sugimoto; Fumiko Honda; Daisuke Maeda; Mitsuko Masutani; Tohru Kiyono; Fumiaki Watanabe; Tomohiro Morio; Hirobumi Teraoka; Shuki Mizutani
Journal:  Cancer Sci       Date:  2013-04-15       Impact factor: 6.716

Review 5.  Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment.

Authors:  Ashok R Venkitaraman
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

6.  BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations.

Authors:  Q Ye; Y F Hu; H Zhong; A C Nye; A S Belmont; R Li
Journal:  J Cell Biol       Date:  2001-12-10       Impact factor: 10.539

7.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

8.  Atlas of RNA sequencing profiles for normal human tissues.

Authors:  Maria Suntsova; Nurshat Gaifullin; Daria Allina; Alexey Reshetun; Xinmin Li; Larisa Mendeleeva; Vadim Surin; Anna Sergeeva; Pavel Spirin; Vladimir Prassolov; Alexander Morgan; Andrew Garazha; Maxim Sorokin; Anton Buzdin
Journal:  Sci Data       Date:  2019-04-23       Impact factor: 6.444

9.  Algorithmic Annotation of Functional Roles for Components of 3,044 Human Molecular Pathways.

Authors:  Maxim Sorokin; Nicolas Borisov; Denis Kuzmin; Alexander Gudkov; Marianna Zolotovskaia; Andrew Garazha; Anton Buzdin
Journal:  Front Genet       Date:  2021-02-09       Impact factor: 4.599

Review 10.  Interplay between Fanconi anemia and homologous recombination pathways in genome integrity.

Authors:  Johanna Michl; Jutta Zimmer; Madalena Tarsounas
Journal:  EMBO J       Date:  2016-04-01       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.